GOLDMAN SACHS GROUP INC - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q2 2024$56,200,566
+55.2%
1,448,095
+28.9%
0.01%
+66.7%
Q1 2024$36,208,794
+19.9%
1,123,450
+6.7%
0.01%0.0%
Q4 2023$30,207,411
+73.9%
1,053,257
+67.9%
0.01%
+50.0%
Q3 2023$17,367,678
-6.9%
627,445
-10.1%
0.00%0.0%
Q2 2023$18,662,914
-24.2%
697,679
-38.6%
0.00%
-33.3%
Q1 2023$24,607,016
+3.2%
1,136,058
+13.5%
0.01%0.0%
Q4 2022$23,848,989
+116140.1%
1,001,217
-3.8%
0.01%
+20.0%
Q3 2022$20,517
+18.3%
1,040,426
+17.0%
0.01%
+25.0%
Q2 2022$17,336
-99.9%
889,497
+2.3%
0.00%
-20.0%
Q1 2022$22,181,000
+26.9%
869,507
+25.3%
0.01%
+66.7%
Q4 2021$17,473,000
-34.8%
694,203
-28.7%
0.00%
-50.0%
Q3 2021$26,792,000
+19.9%
973,898
+38.3%
0.01%
+20.0%
Q2 2021$22,353,000
-31.1%
704,257
-0.3%
0.01%
-37.5%
Q1 2021$32,423,000
+61.5%
706,691
+39.4%
0.01%
+60.0%
Q4 2020$20,074,000
+972.3%
507,066
+842.6%
0.01%
+400.0%
Q3 2020$1,872,000
-54.0%
53,794
-58.3%
0.00%0.0%
Q2 2020$4,068,000
+182.7%
128,850
+96.2%
0.00%0.0%
Q1 2020$1,439,00065,6880.00%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 5,104,130$99,479,00040.69%
Ponoi II Management, LLC 685,011$13,351,00036.28%
Nextech Invest Ltd. 3,939,529$76,781,00025.90%
Ponoi Management, LLC 685,011$13,351,00021.08%
Column Group LLC 4,395,050$85,660,00018.23%
TRV GP IV, LLC 1,419,900$27,674,00018.20%
Boxer Capital, LLC 3,484,264$67,908,0004.30%
Casdin Capital, LLC 2,370,000$46,191,0003.91%
Cormorant Asset Management, LP 1,995,066$38,884,0002.94%
EcoR1 Capital, LLC 4,278,069$83,380,0002.88%
View complete list of REVOLUTION MEDICINES INC shareholders